MYH9 and breast carcinoma: To investigate whether FATS enhances the effect of paclitaxel on breast cancer cells by promoting the degradation of the MYH9 protein, we co-transfected FATS and MYH9 overexpression plasmids into MCF-7 and MDA-MB-231 cells.